Screening nephroprotective compounds from cortex Moutan by mesangial cell extraction and UPLC.

Area of Science:

• Pharmacology
• Traditional Chinese Medicine
• Nephrology

Background:

• Diabetic nephropathy is a major complication of diabetes, often treated with traditional Chinese medicine (TCM).
• Identifying active compounds in TCMs like Cortex Moutan is crucial for developing effective treatments.
• Cell membrane binding under pathological conditions is hypothesized to indicate bioactive compounds in TCMs.

Purpose of the Study:

• To develop a novel method for screening nephroprotective compounds from Cortex Moutan.
• To identify specific compounds in Cortex Moutan that protect against diabetic nephropathy.
• To validate the therapeutic potential of identified compounds through in vitro studies.

Main Methods:

• Culturing rat renal mesangial cells under normal (NG) and high glucose (HG) conditions.
• Incubating cells with Cortex Moutan extract and isolating cell membrane-bound compounds using Solid Phase Extraction (SPE).
• Analyzing compounds using Ultra-Performance Liquid Chromatography (UPLC) and conducting in vitro assays to assess their effects on cellular damage markers.

Main Results:

• Paeoniflorin, pentagalloylglucose (PGG), and paeonol were identified as compounds binding to mesangial cells under both NG and HG conditions.
• These three compounds significantly reduced nicotinamide-adenine dinucleotide phosphate oxidase (NADPH) activity and reactive oxygen species (ROS) levels in HG-cultured cells.
• Paeoniflorin, PGG, and paeonol also decreased the levels of transforming growth factor-β1 (TGF-β1) and fibronectin, key markers of kidney damage.

Conclusions:

• Paeonol, paeoniflorin, and PGG are identified as the primary nephroprotective compounds in Cortex Moutan.
• The study presents a reliable method for screening bioactive compounds from complex TCM formulations.
• These findings support the use of Cortex Moutan in managing diabetic nephropathy and offer potential therapeutic leads.